SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 408 participants.

Also called NCT05801627

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 408 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05801627
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05801627. Randomized; quadruple masking; primary purpose treatment. Start 2020-05-06 (actual); primary completion 2022-05-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
SAL067
Intervention (Drug)
Placebo
Lead sponsor
Shenzhen Salubris Pharmaceuticals Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05801627
Content hash
14fd95d7e6c94530f163e9854fcd84802de447d1d0eb97c30d568d32f770f1b7